Effectiveness of biosimilar drugs in the treatment of renal anemia: A case series
Introduction Patients with chronic kidney disease usually have anemia secondary to an erythropoietin deficit. The emergence of biosimilar drugs of erythropoiesis-stimulating agents ensures broader access to these treatments. Objective This study analyzes the effectiveness of an epoetin α biosim...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | article |
| Langue: | EN ES |
| Publié: |
Medwave Estudios Limitada
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/a2ce73468f3043b2a5060f8e35081468 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|